Evidence map›Paper›PMID 35923596›Full record

ArticleCritical care explorations2022

Opioid Prescribing Patterns Before, During, and After Critical Illness: An Observational Study.

Chelsea Wampole, Ariel McKenna, Richard R Riker, Teresa L May, David B Seder, Dawn Abram, Gilles L Fraser, David J Gagnon

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chelsea WampoleDepartment of Pharmacy, Maine Medical Center, Portland, ME.
Ariel McKennaDepartment of Medicine, Maine Medical Center, Portland, ME.
Richard R RikerDepartment of Critical Care Services, Maine Medical Center, Portland, ME.
Teresa L MayDepartment of Critical Care Services, Maine Medical Center, Portland, ME.
David B SederDepartment of Critical Care Services, Maine Medical Center, Portland, ME.
Dawn AbramEnterprise Data Management, MaineHealth Information Technology, Westbrook, ME.
Gilles L FraserTufts University School of Medicine, Boston, MA.
David J GagnonDepartment of Pharmacy, Maine Medical Center, Portland, ME.
Maine Medical Center · USTufts University · USMaine Medical Center Research Institute · US

Funding

Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal EncephalopathyP20GM139745 · NIGMS · MAINEHEALTH · PI David B. Seder · 2021 to 2026
$19.2M
NIGMS NIH HHS P20 GM139745
6 · The paper itself

Abstract

objectivesThe association between opioid therapy during critical illness and persistent opioid use after discharge is understudied relative to ICU opioid exposure and modifiable risk factors. Our objectives were to compare persistent opioid use after discharge among patients with and without chronic opioid use prior to admission (OPTA) and identify risk factors associated with persistent use.

designRetrospective cohort study.

settingMedical, trauma/surgical, or neurologic ICU at an academic hospital.

participantsAdult patients surviving hospital admission.

interventionsOpioid use during the ICU and post-ICU stays. MEASUREMENTS AND MAIN

resultsThe primary outcome was persistent opioid use accounting for greater than 70% of days 4-6 months after discharge. Among 2,975 included patients, 257 (8.6%) were classified as OPTA, and 305 (10.2%) persistently filled opioid prescriptions, including 186/257 (72%) OPTA and 119/2,718 (4.4%) with no chronic opioid fills prior to admission. Among all patients, OPTA was strongly associated with persistent opioid use (odds ratio, 57.2 [95% CI, 41.4-80.0]). Multivariable logistic regression revealed that male sex, surgical procedure, and ICU opioid-free days were associated with reduced persistent opioid use for OPTA patients. Age and ICU opioid-free days were associated with reduced persistent opioid use for non-OPTA patients. Total ICU opioid dose and dose per day of ICU exposure were not associated with persistent use for either group.

conclusionsIn this mixed cohort of ICU patients, 10.2% persistently filled opioid prescriptions 4-6 months after discharge. Although ICU opioid doses were not associated with persistent use, duration of ICU opioid administration is a modifiable risk factor that may reduce persistent opioid use after critical illness.

Indexed as

analgesiaanalgesicsepidemicintensive care unitopioidpainsedation

Identifiers

PMID35923596
PMCPMC9329077
OpenAlexW4288045515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.